儿童多系统炎症综合征与儿童COVID-19的免疫病理特征
这项纵向多机构研究应用多组学方法分析了儿童COVID-19(n=110)、儿童多系统炎症综合征(MIS-C,n=76)及儿童健康对照(n=76)。儿童COVID-19以强I型干扰素应答为特征,而MIS-C则表现为II型干扰素依赖和NF-κB依赖特征、基质体激活及循环刺突蛋白升高。MIS-C中TRBV11-2 T细胞克隆短暂扩增并与炎症和T细胞活化相关,且MIS-C与HLA A*02、B*35和C*04等位基因组合相关,提示遗传易感性。
要点
- 儿童COVID-19以强I型干扰素应答为特征。
- MIS-C表现为II型干扰素依赖和NF-κB依赖特征、基质体激活及循环刺突蛋白升高。
- MIS-C中TRBV11-2 T细胞克隆短暂扩增,与炎症和T细胞活化相关。
核心结论
- 儿童COVID-19与MIS-C具有不同的免疫病理特征,可能有助于更好地定义其病理生理并指导治疗。
研究设计与样本
- 纵向多机构研究,应用多组学(可溶性生物标志物、蛋白质组学、单细胞基因表达和免疫组库分析)分析儿童COVID-19(n=110)、MIS-C(n=76)及儿童健康对照(n=76)。
主要发现
- 儿童COVID-19以强I型干扰素应答为特征。
- MIS-C中检测到显著的II型干扰素依赖和NF-κB依赖特征、基质体激活及循环刺突蛋白水平升高,且与入院前后SARS-CoV-2 PCR状态无相关性。
- MIS-C中TRBV11-2 T细胞克隆短暂扩增,与炎症和T细胞活化特征相关。
- MIS-C与HLA A*02、B*35和C*04等位基因组合相关,提示遗传易感性。
- MIS-C的B细胞突变负荷高于儿童COVID-19和儿童健康对照。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pediatric Coronavirus Disease 2019 (pCOVID-19) is rarely severe; however, a minority of children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might develop multisystem inflammatory syndrome in children (MIS-C), with substantial morbidity. In this longitudinal multi-institutional study, we applied multi-omics (analysis of soluble biomarkers, proteomics, single-cell gene expression and immune repertoire analysis) to profile children with COVID-19 (n = 110) and MIS-C (n = 76), along with pediatric healthy controls (pHCs; n = 76). pCOVID-19 was characterized by robust type I interferon (IFN) responses, whereas prominent type II IFN-dependent and NF-κB-dependent signatures, matrisome activation and increased levels of circulating spike protein were detected in MIS-C, with no correlation with SARS-CoV-2 PCR status around the time of admission. Transient expansion of TRBV11-2 T cell clonotypes in MIS-C was associated with signatures of inflammation and T cell activation. The association of MIS-C with the combination of HLA A*02, B*35 and C*04 alleles suggests genetic susceptibility. MIS-C B cells showed higher mutation load than pCOVID-19 and pHC. These results identify distinct immunopathological signatures in pCOVID-19 and MIS-C that might help better define the pathophysiology of these disorders and guide therapy.
引用
- Sacco K, Castagnoli R, Vakkilainen S, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med. 2022. PMID: 35177862. doi:10.1038/s41591-022-01724-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。